MCA stability tool

Check whether tablets and capsules are suitable for a multi-compartment compliance aid (MCA), and build a list to print.

Browse medicines A to Z

A (medicines beginning with A) B (medicines beginning with B) C (medicines beginning with C) D (medicines beginning with D) E (medicines beginning with E) F (medicines beginning with F) G (medicines beginning with G) H (medicines beginning with H) I (medicines beginning with I) K (medicines beginning with K) L (medicines beginning with L) M (medicines beginning with M) N (medicines beginning with N) O (medicines beginning with O) P (medicines beginning with P) Q (medicines beginning with Q) R (medicines beginning with R) S (medicines beginning with S) T (medicines beginning with T) U (medicines beginning with U) V (medicines beginning with V) W (medicines beginning with W) X (medicines beginning with X) Y (medicines beginning with Y) Z (medicines beginning with Z)

Medicines beginning with V

Valganciclovir

Valganciclovir 450mg tablets

No stability information

Stability notes for Valganciclovir 450mg tablets

There are no stability notes for this medicine.

Suppliers (11) of Valganciclovir 450mg tablets
Valcyte 450mg tablets (Neon Healthcare Ltd)
Valganciclovir 450mg tablets (A A H Pharmaceuticals Ltd)
Valganciclovir 450mg tablets (Alliance Healthcare (Distribution) Ltd)
Valganciclovir 450mg tablets (Amarox Ltd)
Valganciclovir 450mg tablets (Cipla EU Ltd)
Valganciclovir 450mg tablets (Glenmark Pharmaceuticals Europe Ltd)
Valganciclovir 450mg tablets (Medihealth (Northern) Ltd)
Valganciclovir 450mg tablets (Medreich Plc)
Valganciclovir 450mg tablets (Milpharm Ltd)
Valganciclovir 450mg tablets (Torrent Pharma (UK) Ltd)
Valganciclovir 450mg tablets (Viatris UK Healthcare Ltd)

What the ratings mean

Compatible
Suitable for use. Keep in MCA for shortest possible time: no more than 5 weeks for non-airtight; 8 weeks for airtight. Use likely to be off-label.
Use with caution
Suitable with mitigations. Keep in MCA for shortest possible time: no more than 5 weeks for non-airtight; 8 weeks for airtight. Use likely to be off-label and supported by limited data.
Incompatible
Medicines under this category are not suitable for use in MCAs.
No stability information
These medicines have not been reviewed by SPS.